T37.5X2 Poisoning by antiviral drugs, intentional self-harm

Name of the Condition

• Poisoning by antiviral drugs, intentional self-harm

Summary

This condition involves intentional self-harm resulting from exposure to antiviral medications, leading to poisoning. It includes deliberate ingestion or administration of antiviral agents with the intent to cause harm, which may result in acute toxicity or overdose. The term "intentional self-harm" distinguishes this from accidental or therapeutic use, emphasizing the deliberate nature of the exposure.

Causes

Intentional self-harm by antiviral drugs occurs when a patient deliberately takes an excessive or inappropriate dose of these medications. This may involve ingesting multiple doses, using the wrong formulation, or combining antiviral drugs with other substances to enhance toxicity. The underlying motivation often relates to psychological distress or suicidal intent.

Risk Factors

• History of mental health conditions, such as depression or anxiety.
• Prior episodes of self-harm or suicidal behavior.
• Access to antiviral medications, particularly in home settings.
• Social isolation or lack of support systems.
• Substance use disorders that may impair judgment.

Symptoms

• Gastrointestinal: Nausea, vomiting, abdominal pain, or diarrhea.
• Neurological: Dizziness, confusion, seizures, or altered mental status.
• Cardiovascular: Hypotension, tachycardia, or arrhythmias.
• Hepatic: Elevated liver enzymes or signs of liver failure.
• Renal: Acute kidney injury or electrolyte imbalances.
• Dermatological: Rash, blistering, or hypersensitivity reactions.

Diagnosis

Clinical evaluation focuses on patient history, including details of the exposure and intent. Laboratory tests assess drug levels, organ function (e.g., liver and kidney panels), and toxicology screens. Imaging or other studies may be used to evaluate complications, such as organ damage or metabolic disturbances. Psychiatric assessment is critical to address underlying mental health concerns.

Treatment Options

Management includes stabilizing the patient, decontamination (if appropriate), and supportive care (e.g., fluid resuscitation, monitoring vital signs). Specific antidotes or treatments for antiviral toxicity may be administered based on the agent involved. Psychiatric intervention, such as counseling or crisis support, is essential to address the underlying intent and prevent recurrence.

Prognosis and Follow-Up

Prognosis depends on the severity of poisoning, timeliness of treatment, and underlying mental health status. Early intervention improves outcomes, but severe toxicity may lead to long-term organ damage or mortality. Follow-up includes monitoring for complications, ongoing psychiatric care, and safety planning to reduce future risk.

Complications

• Organ failure (e.g., hepatic, renal, or cardiac).
• Neurological damage, including seizures or cognitive impairment.
• Metabolic disturbances, such as electrolyte imbalances.
• Psychological sequelae, such as depression or PTSD.
• Increased risk of future self-harm or suicide.

Lifestyle & Prevention

• Secure storage of medications to limit access.
• Education on safe medication use and disposal.
• Mental health support and crisis resources for at-risk individuals.
• Regular monitoring of patients with a history of self-harm.
• Collaboration with healthcare providers to address underlying conditions.

When to Seek Professional Help

Seek immediate medical attention if intentional self-harm with antiviral drugs is suspected or confirmed. Signs of toxicity, such as severe nausea, confusion, or difficulty breathing, require urgent evaluation. Psychiatric care should be initiated promptly to address the underlying intent and prevent recurrence.

Tips for Medical Coders

Document the intent (intentional self-harm) and any contributing factors, such as the specific antiviral agent involved or the severity of poisoning. Ensure clinical details support the diagnosis, including patient history, symptoms, and treatment provided. Use this code for encounters related to the acute event and follow-up care, as appropriate.